Denali Therapeutics Inc (DNLI)

Working Capital Ratio

57.33%

Quarterly · Period ending:

DNLI logo

DNLI Working Capital Ratio

Latest reported70.08%
DNLI FY Working Capital Ratio (81.65% → 70.08%)
High-resolution chart · PNG

DNLI working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
70.0794%
55.4678%
85.4615%
69.0568%
36.9608%
88.7598%
69.5346%
67.6829%
81.2463%
63.7662%
81.6454%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.